30 \30\Europe/Madrid June \30\Europe/Madrid 2026
Following the implementation of Germany’s cannabis reform framework, including the CanG, and in light of the recent cannabis-related developments and debates, which aspects do you believe have worked best so far, where is urgent regulatory review needed, and how...
28 \28\Europe/Madrid May \28\Europe/Madrid 2026
Key Marketing Strategies in the European Medical Cannabis Market: What Actually Moves the Needle The US and Canadian markets were built on commercialization: loud branding, aggressive customer acquisition, and retail competition. The European market was built on...
30 \30\Europe/Madrid April \30\Europe/Madrid 2026
It is a pleasure to contribute to a publication that, in my view, reflects very well the resilience, professionalism, and delivery capacity that this sector needs. After almost eight years working closely with the medical cannabis industry, I have seen first-hand how...
31 \31\Europe/Madrid March \31\Europe/Madrid 2026
Do you think the main challenge facing medical cannabis today is related to public perception, regulation, or a lack of talent in the sector? Regulation moves when the industry is credible. Regulators don’t wake up one day and decide they’ve “gone soft” on cannabis —...
26 \26\Europe/Madrid February \26\Europe/Madrid 2026
Based on your experience as a legal expert in the cannabis sector, what are currently the main legal risks and conflicts affecting promoters of medical cannabis projects in Spain? European Spotlight: Remote Dispensing, Justice, and the Role of the Judicial Expert in...
